Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siebner

Showing results (561-570 of 637) with videos related to

Pageof 64
Sort By:
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|August 6, 2025
Emergent technologies in clinical neurophysiology to study the central nervous system: IFCN handbook chapterAdrian G Guggisberg, Hartwig R Siebner, Henrik Lundell, et al.
Scientific Reports|April 28, 2026
Magnetic resonance imaging-derived extracellular volume fraction mapping in metabolic dysfunction-associated steatotic liver disease reveals subclinical cardiac remodellingPuria Nabilou, Signe Wiese, Liv E Hetland, et al.
Frontiers in Psychiatry|December 31, 2025
Acute effects of partial positive allosteric GABA<sub>A</sub> receptor modulation by GT-002 on psychophysiological and cognitive measures: protocol for the TOTEMS phase II trial targeting cognitive impairment associated with schizophreniaThomas Hartwig Siebner, Karen Sandø Ambrosen, Cecilie Koldbæk Lemvigh, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 4, 2015
Monthly oral methylprednisolone pulse treatment in progressive multiple sclerosisRikke Ratzer, Pernille Iversen, Lars Börnsen, et al.
Multiple Sclerosis and Related Disorders|July 7, 2023
NfL and GFAP in serum are associated with microstructural brain damage in progressive multiple sclerosisC Ammitzbøll, T B Dyrby, L Börnsen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 21, 2015
Trichuris suis ova therapy in relapsing multiple sclerosis is safe but without signals of beneficial effectA Voldsgaard, P Bager, E Garde, et al.
Frontiers in Neuroscience|April 1, 2022
Uncovering Cortical Units of Processing From Multi-Layered ConnectomesKristoffer Jon Albers, Matthew G Liptrot, Karen Sandø Ambrosen, et al.
Multiple Sclerosis and Related Disorders|October 18, 2022
Relationship between cerebrospinal fluid biomarkers of inflammation and tissue damage in primary progressive multiple sclerosisJacob Talbot, Helene Højsgaard Chow, Mie Mahler, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 13, 2025
Increased Blood Flow and Tendon Swelling Precedes Vascular Expansion and Tissue Matrix Changes In Early Human Tendinopathy: A Potential Window for Superior Treatment ResponseMax F R Merkel, Nikolaj M Malmgaard-Clausen, Marius Lendal, et al.
Trials|March 23, 2023
Patient-tailored transcranial direct current stimulation to improve stroke rehabilitation: study protocol of a randomized sham-controlled trialMia Kolmos, Mads Just Madsen, Marie Louise Liu, et al.
Pageof 64

Showing results (561-570 of 637) with videos related to

Sort By:
Pageof 64
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|August 6, 2025
Emergent technologies in clinical neurophysiology to study the central nervous system: IFCN handbook chapterAdrian G Guggisberg, Hartwig R Siebner, Henrik Lundell, et al.
Scientific Reports|April 28, 2026
Magnetic resonance imaging-derived extracellular volume fraction mapping in metabolic dysfunction-associated steatotic liver disease reveals subclinical cardiac remodellingPuria Nabilou, Signe Wiese, Liv E Hetland, et al.
Frontiers in Psychiatry|December 31, 2025
Acute effects of partial positive allosteric GABA<sub>A</sub> receptor modulation by GT-002 on psychophysiological and cognitive measures: protocol for the TOTEMS phase II trial targeting cognitive impairment associated with schizophreniaThomas Hartwig Siebner, Karen Sandø Ambrosen, Cecilie Koldbæk Lemvigh, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 4, 2015
Monthly oral methylprednisolone pulse treatment in progressive multiple sclerosisRikke Ratzer, Pernille Iversen, Lars Börnsen, et al.
Multiple Sclerosis and Related Disorders|July 7, 2023
NfL and GFAP in serum are associated with microstructural brain damage in progressive multiple sclerosisC Ammitzbøll, T B Dyrby, L Börnsen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 21, 2015
Trichuris suis ova therapy in relapsing multiple sclerosis is safe but without signals of beneficial effectA Voldsgaard, P Bager, E Garde, et al.
Frontiers in Neuroscience|April 1, 2022
Uncovering Cortical Units of Processing From Multi-Layered ConnectomesKristoffer Jon Albers, Matthew G Liptrot, Karen Sandø Ambrosen, et al.
Multiple Sclerosis and Related Disorders|October 18, 2022
Relationship between cerebrospinal fluid biomarkers of inflammation and tissue damage in primary progressive multiple sclerosisJacob Talbot, Helene Højsgaard Chow, Mie Mahler, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 13, 2025
Increased Blood Flow and Tendon Swelling Precedes Vascular Expansion and Tissue Matrix Changes In Early Human Tendinopathy: A Potential Window for Superior Treatment ResponseMax F R Merkel, Nikolaj M Malmgaard-Clausen, Marius Lendal, et al.
Trials|March 23, 2023
Patient-tailored transcranial direct current stimulation to improve stroke rehabilitation: study protocol of a randomized sham-controlled trialMia Kolmos, Mads Just Madsen, Marie Louise Liu, et al.
Pageof 64